Fibromyalgia and Trauma: When the Body’s Pain Continues the Story

Fibromyalgia often presents as an enigma of modern medicine: body-wide pain, fatigue, sleep disturbances, and anxiety. But a new study by a Spanish-European group shows what patients have intuitively felt for years: behind the chronic pain, there is often a long biography of psychological trauma, especially from early life. And this is not just a backdrop, but a factor linked to the onset of pain, its intensity, and the accompanying psychological symptoms. In a sample of 88 women diagnosed with fibromyalgia, 71.5% met the criteria for current PTSD, and in 84%, traumatic events had occurred before the onset of pain. That is, for the majority, the traumatic experience came first, and then the chronic pain, which seems to have “taken up” this story and continued it in the body.

What was investigated and what was found

The authors systematically described traumas throughout the lifespan, from the first years to maturity, and correlated them with pain, anxiety, depression, insomnia, and quality of life. In childhood and early adolescence, emotional abuse and emotional deprivation were most common, followed by sexual and physical abuse. It is important to highlight this not to sensationalise a “difficult childhood,” but because it is these subtypes that are linked to a lower quality of life in adulthood.

Statistical models confirm clinical intuition: the higher the pain and functional limitations in fibromyalgia, the more pronounced the depressive and anxious symptomatology, the higher the level of insomnia, and the more frequent the dissociative experiences. In contrast, it was childhood traumas that predicted lower life satisfaction. Notably, physical deprivation in childhood was separately associated with greater pain intensity on the Visual Analogue Scale (VAS). In other words, an early lack of basic care and safety can “teach” the body to hurt more intensely and for longer.

The patient profile from the study appears severe, but is surprisingly recognisable to practising clinicians: an average pain score of around 6.6 out of 10, significant limitations in daily activities, almost universal insomnia, high anxiety and depression, comorbid chronic fatigue syndrome in 60%, and a delayed diagnostic trajectory with a delay of almost a decade between the onset of pain and diagnosis. A separate concern is the history of suicidal thoughts in 82.9% and attempts in 32.9% of patients. This underlines not a “weakness” in the patients, but the severity of the illness’s burden and the need for a multidisciplinary perspective from the very first appointments.

Why does this happen, and how does fibromyalgia develop

From a neurobiological perspective, fibromyalgia develops where central nervous system sensitisation and chronic stress meet. Early traumas during a period of high brain plasticity recalibrate the hypothalamic-pituitary-adrenal (HPA) axis and the subtle regulatory circuits of “fear and safety.” As a result, cortisol is less effective in its anti-inflammatory and anti-stress role, and the systems for inhibiting pain signals work less efficiently. In practice, this means the pain system becomes hyperexcitable, and its ‘brakes’ wear out prematurely. This is why ordinary stimuli — cold, exertion, lack of sleep — begin to “hit harder” than they should. Such a circuit maintains and deepens the phenomenon of central sensitisation — a key mechanism of fibromyalgia in which the brain and spinal cord amplify incoming pain information and are less effective at filtering it.

If we describe the development of fibromyalgia briefly, it follows a sequence of steps. Step one — recurring or prolonged stressors, often starting from childhood. Step two — a recalibration of the stress and pain systems, with a “sticking point” at the level of sensory and emotional circuits. Step three — the chronification of symptoms: the pain becomes widespread, joined by sleep disturbances, fatigue, reduced cognitive endurance, anxiety, and depression. Step four — secondary perpetuating cycles: avoiding activity due to pain leads to deconditioning, insomnia worsens sensitisation, and comorbid syndromes and social stress feed the vicious circle. In this context, it is not surprising that pain is a strong predictor of anxiety, depression, insomnia, and dissociation — both because it is severe in itself, and because it is embedded in the body’s overall stress profile.

It is important to emphasise two points that are often lost in media debates. Firstly, this is not about linear causality of “one trauma — one diagnosis,” but about an accumulation of risk and vulnerability. The study clearly records a high proportion of traumas before the onset of pain and an extremely high prevalence of current PTSD, but it acknowledges the multifactorial nature of the condition and the variability of its trajectories. Secondly, emotional trauma does not “psychologise” fibromyalgia. It explains some of the neurobiological settings that make pain more likely and more persistent, and therefore gives the clinician additional levers for help, from working with the trauma to targeted correction of sleep and activity.

What can be done

The first practical step is at the level of diagnosis and language. An adult patient with chronic widespread pain deserves a gentle inquiry about early and later traumas. This is not about finding who is to blame, but about finding paths we can walk together. If history is dominated by threat-based events, it is logical to rely on trauma-informed psychotherapy that reprocesses traumatic memories and fear reactions. If deprivation is the dominant theme, it is worth strengthening the circuits of support, somatic and sensory regulation, and working on boundaries and connection. In parallel, basic “body anchors” are necessary: sleep stabilisation, gradual aerobic activity with paced exertion, nutritional strategies with an anti-inflammatory profile, and work on daily rhythms and safe stress hygiene.

The second step is teamwork. The study shows how frequently fibromyalgia coexists with anxiety, depression, insomnia, somatic disorders, and chronic fatigue syndrome. This signifies a real need for a pathway where a rheumatologist, GP, psychotherapist, psychiatrist, pain specialist, and where necessary, a neurologist and endocrinologist work together. Such a pathway reduces the time to a working hypothesis, saves years of fruitless bouncing between diagnoses, and increases the chance of a personalised care plan.

The third step is acknowledging the role of trauma-oriented therapy. The traumatic imprint does not disappear on its own, but it can be reprocessed. Modern approaches allow for the safe and targeted changing of the ‘settings’ of memory and reactivity. On the continuum of such solutions, there are innovative methods, for example, Mental Engineering — an approach focused on reprocessing traumatic images and restoring a sense of agency. The primary goal here is psychological regulation and restoring control, while possible somatic effects — reduced stress levels, improved sleep, indirect weakening of sensitisation — require study and monitoring. But integrating such methods into the overall plan makes the support not only more humane but also potentially more effective in the long run.

Finally, the fourth step is risk management. Given the high proportion of suicidal thoughts and past attempts in patients with fibromyalgia, regular suicide risk assessment should become routine, on a par with measuring pain and sleep. This is not a matter of stigma, but of safety and quality of care.

This study shifts the conversation about fibromyalgia from the plane of “it’s all in your head” to that of a complex dialogue between the body and memory, between sensitisation and the stories that made us more vulnerable. Trauma does not explain everything, but it explains enough for us to stop treating the symptom in isolation from the biography. And if pain can inherit the voice of the past, is it not time for us to learn to speak to it in a language that both the body and memory can hear — and to ask ourselves a direct question: are we ready to build a treatment as deep as the trauma that has changed the organism?